BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12056931)

  • 1. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease.
    Chantal S; Labelle M; Bouchard RW; Braun CM; Boulanger Y
    Arch Neurol; 2002 Jun; 59(6):955-62. PubMed ID: 12056931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease.
    Chantal S; Braun CM; Bouchard RW; Labelle M; Boulanger Y
    Brain Res; 2004 Apr; 1003(1-2):26-35. PubMed ID: 15019560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD.
    Jessen F; Block W; Träber F; Keller E; Flacke S; Papassotiropoulos A; Lamerichs R; Heun R; Schild HH
    Neurology; 2000 Sep; 55(5):684-8. PubMed ID: 10980734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
    Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
    Ding B; Chen KM; Ling HW; Zhang H; Chai WM; Li X; Wang T
    Dement Geriatr Cogn Disord; 2008; 25(3):218-25. PubMed ID: 18219201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
    Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proton spectroscopy in Alzheimer's disease and cognitive impairment not dementia: a community study].
    Azevedo D; Bottino CM; Tatsch M; Hototian SR; Bazzarella MC; Castro CC
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1021-7. PubMed ID: 16400423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Rami L; Gómez-Ansón B; Bosch B; Sánchez-Valle R; Monte GC; Villar A; Molinuevo JL
    Dement Geriatr Cogn Disord; 2007; 24(4):274-9. PubMed ID: 17717413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD; Rai GS
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Pina MA
    Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.
    Pfefferbaum A; Adalsteinsson E; Spielman D; Sullivan EV; Lim KO
    Arch Gen Psychiatry; 1999 Feb; 56(2):185-92. PubMed ID: 10025444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
    Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease.
    Block W; Jessen F; Träber F; Flacke S; Manka C; Lamerichs R; Keller E; Heun R; Schild H
    Arch Neurol; 2002 May; 59(5):828-34. PubMed ID: 12020267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study.
    Schott JM; Frost C; MacManus DG; Ibrahim F; Waldman AD; Fox NC
    Brain; 2010 Nov; 133(11):3315-22. PubMed ID: 20739347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.